17 α-Hydroxyprogesterone Caproate (Makena™): In the Prevention of Preterm Birth

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.13, Iss.5, 2011-10, pp. : 337-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

17α -Hydroxyprogesterone caproate versus intravaginal progesterone in IVF–embryo transfer cycles: a prospective randomized study

By Unfer Vittorio Casini Maria Luisa Costabile Loredana Gerli Sandro Baldini Domenico Di Renzo Gc

Reproductive BioMedicine Online, Vol. 9, Iss. 1, 2004-07 ,pp. : 17-21

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection

By Chollet John L. Jozwiakowski Michael J.

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 5, 2012-05 ,pp. : 540-549

Informa Healthcare

Access to resources Recommend Favorite

Maternal Immunomodulation Therapy for Prevention of Preterm Birth and Prematurity-Related Morbidity: The New Era of Immuno-Perinatology

Current Pharmaceutical Design, Vol. 23, Iss. 40, 2018-02 ,pp. : 6125-6131

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation, Infection and Preterm Birth

Current Pharmaceutical Design, Vol. 20, Iss. 29, 2014-09 ,pp. : 4741-4748

Bentham Science Publishers

Access to resources Recommend Favorite

Benzodiazepines implicated in preterm birth

Reactions Weekly, Vol. 1, Iss. 1298, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite